MedTrace Logo

RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)

NCT03053141 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-05-04

No results posted yet for this study

Summary

The objective of the RHAPSODY study is to evaluate the performance of new software features in subjects undergoing standard of care catheter-based endocardial mapping for atrial or ventricular tachyarrhythmias using a commercial Rhythmia Mapping System. Results from this study will be used to guide development and refinement of new software features that may be implemented in future commercial software releases.

Conditions

  • Cardiac Arrythmias

Interventions

DEVICE

Rhythmia Mapping System

The Rhythmia Mapping System is a 3D electro-anatomical mapping system.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Thomas H McElderry, MD · University of Alabama at Birmingham

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States
  • Italy
  • Monaco

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03053141 on ClinicalTrials.gov